← Open Payments lookup

MARKUS PLOESSER: Open Payments

NPI 1669662755 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$27,734 in 69 payments from 14 companies in 2025. Trend: 2023 $41,433 · 2024 $34,747 · 2025 $27,734

Speaker / faculty: $15,920Consulting: $7,460Food & beverage: $2,759Travel & lodging: $1,595
CompanyPaymentsAmount
Alkermes, Inc.28$15,072
Teva Pharmaceuticals USA, Inc.12$11,124
Medtronic, Inc.5$349
Neurocrine BioSciences, Inc.4$214
Otsuka America Pharmaceutical, Inc.5$203
Avanos Medical1$163
Boston Scientific Corporation1$162
Abbott Laboratories1$147
E.R. Squibb & Sons, L.L.C.4$94
Vanda Pharmaceuticals Inc.3$85

Products named: LYBALVI, UZEDY, ARISTADA, INGREZZA, REXULTI, SYNCHROMEDII, COOLIEF COOLED RADIOFREQUENCY, General - Pain Management.

Industry payments across CA — which companies pay providers there.